Visible‐Light‐Promoted Difluoromethylation/Cyclization of 1‐Acryloyl‐2‐cyanoindole for Construction of Difluoromethylated Pyrrolo[1,2‐ a ]indolediones
Advanced Synthesis & Catalysis · 08.03.2024 · 366 (5) · 1158-1164
DOI: 10.1002/adsc.202301173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Synthesis & Catalysis, online erschienen am 23.01.2024. Verfasst von Hongzhao Qu und 7 weiteren Autor:innen. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Henan University of Technology.
Abstract (Originalsprache)
A visible‐light‐promoted cascade difluoromethylation/cyclization reaction to access various difluoromethylated pyrrolo[1,2‐ a ]indolediones was developed using difluoromethyltriphenylphosphonium bromide salt as the difluoromethylating reagent. A possible radical mechanism has been investigated and proven as a single electron transfer (SET) procedure.
Förderung
- Henan University of Technology
Zitieren
APA
Qu, H., Yuan, J., Feng, Z., Guo, N., Yin, Y., Yang, L., Xiao, Y., & Qu, L. (2024). Visible‐Light‐Promoted Difluoromethylation/Cyclization of 1‐Acryloyl‐2‐cyanoindole for Construction of Difluoromethylated Pyrrolo[1,2‐ a ]indolediones. Advanced Synthesis & Catalysis, 366(5), 1158-1164. https://doi.org/10.1002/adsc.202301173
Vancouver
Qu H, Yuan J, Feng Z, Guo N, Yin Y, Yang L, et al. Visible‐Light‐Promoted Difluoromethylation/Cyclization of 1‐Acryloyl‐2‐cyanoindole for Construction of Difluoromethylated Pyrrolo[1,2‐ a ]indolediones. Advanced Synthesis & Catalysis. 2024;366(5):1158-1164. doi:10.1002/adsc.202301173
BibTeX
@article{Qu2024,
author = {Qu, Hongzhao and Yuan, Jinwei and Feng, Zhendong and Guo, Na and Yin, Yanli and Yang, Liangru and Xiao, Yongmei and Qu, Lingbo},
title = {Visible‐Light‐Promoted Difluoromethylation/Cyclization of 1‐Acryloyl‐2‐cyanoindole for Construction of Difluoromethylated Pyrrolo[1,2‐ a ]indolediones},
journal = {Advanced Synthesis & Catalysis},
year = {2024},
volume = {366},
number = {5},
pages = {1158--1164},
doi = {10.1002/adsc.202301173}
}
EUVIMED